This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
VISION Trial
Treatment Considerations in the First Line Setting of mCRPC
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Clinical Trials
From the Editor
Search Clinical Trials
Transformative Trials
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
RSNA 2022
SUO 2022
Urologists for Social Responsibility 2023
Upcoming
ASCO GU 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
Advanced Prostate Cancer Consensus Conference (APCCC 2022)
Viewing 1-20 of 49 articles
APCCC 2022: Debate: PSA Directed Treatment for BCR
APCCC 2022: Debate: Imaging Directed Treatment for BCR
APCCC 2022: Who Needs Systemic Treatment With Salvage RT?
APCCC 2022: Biochemical Recurrence After Definitive Radiotherapy of the Prostate – What Are the Local Treatment Options?
APCCC 2022: Who Needs Early Salvage RT and Who Needs Adjuvant RT in 2022?
APCCC 2022: Tumor Genomic Profiling: What Is Relevant and How To Avoid Potential Pitfalls?
APCCC 2022: How To Read a Genomic Testing Report
APCCC 2022: Risk-Adapted Treatment Monitoring in mCRPC
APCCC 2022: Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment
APCCC 2022: Does “Oligoprogressive” Prostate Cancer Exist as a Distinct Clinically Meaningful Entity and if Yes, How To Treat It?
APCCC 2022: How To Follow-Up Patients Who Had PSMA PET As Baseline Imaging
APCCC 2022: How To Interpret and Confirm Lesions Positive on PSMA PET but With No Correlation on CT?
APCCC 2022: What Is the Evidence of Systemic Therapies (Alone or in Combination With MDT) in Oligometastatic mHSPC?
APCCC 2022: How Can Treatment Be Individualized By Using Genomic Classifiers?
APCCC 2022: Can Biology Help Inform Treatment Decisions In the Management of mHSPC?
APCCC 2022: When Low-Volume on Conventional Imaging Goes into High-Volume on Next-Generation Imaging in mHSPC - How Frequent Is This Situation?
APCCC 2022: Genomic and Clinical Markers in nmCRPC
APCCC 2022: Treatment of the Primary or Local Relapse in nmCRPC
APCCC 2022: Treatment De-escalation Strategies in mHSPC
APCCC 2022: The Uptake of New Treatment Options for mHSPC in Real Life -- Education, Access, Use, and Diversity
1
2
3
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free